Award
National Institute of Biomedical Imaging and Bioengineering 5R01EB034660-03
Fluorescence image guided surgery, adjuvant PDT, and the immune response
Recipient
Not specified
Awarded
May 12, 2026
Identifier
5R01EB034660-03
Development of a theranostic agent for fluorescence-guided surgery and photodynamic therapy to improve prostate cancer treatment outcomes.
Description
This project involves developing a theranostic agent for fluorescence-guided surgery and photodynamic therapy targeting prostate cancer, utilizing mouse and canine models, with the goal of improving surgical efficacy and reducing morbidity.